Loading...

Analysts Raise Parker-Hannifin Price Target Amid Buybacks and Positive Earnings Outlook

Published
18 Jul 24
Updated
22 Oct 25
AnalystConsensusTarget's Fair Value
US$802.71
3.8% undervalued intrinsic discount
22 Oct
US$772.00
Loading
1Y
24.2%
7D
5.2%

Author's Valuation

US$802.713.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on22 Oct 25
Fair value Increased 0.72%

Analysts have increased their price target for Parker-Hannifin from $797 to approximately $802.71, citing modest improvements in profit margin and stability in growth expectations. What's in the News On August 21, 2025, Parker-Hannifin increased its remaining number of shares authorized for repurchase to 20,000,000 shares (company filing).

Shared on08 Oct 25
Fair value Increased 1.16%

Analysts have increased their price target for Parker-Hannifin from $787.86 to $797.00. This reflects a modestly improved outlook on anticipated revenue growth and future valuation metrics.

Shared on04 Sep 25

With consensus forecasts for both revenue growth and discount rate unchanged, analysts have maintained their fair value estimate for Parker-Hannifin at $787.86. What's in the News Increased remaining share repurchase authorization to 20,000,000 shares.

Shared on07 May 25
Fair value Increased 12%

Shared on30 Apr 25
Fair value Increased 0.75%

AnalystConsensusTarget has decreased shares outstanding growth rate from 0.0% to -0.0%.

Shared on23 Apr 25
Fair value Decreased 0.25%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 2.78%

AnalystConsensusTarget has decreased revenue growth from 4.2% to 3.8%.

Shared on09 Apr 25
Fair value Decreased 3.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 0.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.27%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 1.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.